SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-008817
Filing Date
2022-04-21
Accepted
2022-04-21 18:32:59
Documents
1
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3977
  Complete submission text file 0001567619-22-008817.txt   5326
Mailing Address
Business Address
OSBORNE DAVID W (Reporting) CIK: 0001252999 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 22842672

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations